Ozempic & other GLP-1 receptor agnonists: the societal impact & controversy of their growing usage

Transcript

so let's let's pivot now and kind of talk about um the current state of obesity which um uh is is is really seeing a success it's it's never seen um and it's been a relatively short period of time I think three years ago very few people knew what semaglutide was um or even OIC which is the trade name given to the diabetes version of that drug where... Read More